Light Chain Bioscience (Novimmune)
VerifiedDevelops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$119—178m (Dealroom.co estimates Jan 2016.)
Company register number CH-660.0.428.998-8
Geneva Canton of Geneva (HQ)
No columns specified